Appolloni, I.; Alessandrini, F.; Menotti, L.; Avitabile, E.; Marubbi, D.; Piga, N.; Ceresa, D.; Piaggio, F.; Campadelli-Fiume, G.; Malatesta, P.
Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma. Viruses 2021, 13, 1677.
https://doi.org/10.3390/v13091677
AMA Style
Appolloni I, Alessandrini F, Menotti L, Avitabile E, Marubbi D, Piga N, Ceresa D, Piaggio F, Campadelli-Fiume G, Malatesta P.
Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma. Viruses. 2021; 13(9):1677.
https://doi.org/10.3390/v13091677
Chicago/Turabian Style
Appolloni, Irene, Francesco Alessandrini, Laura Menotti, Elisa Avitabile, Daniela Marubbi, Noemi Piga, Davide Ceresa, Francesca Piaggio, Gabriella Campadelli-Fiume, and Paolo Malatesta.
2021. "Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma" Viruses 13, no. 9: 1677.
https://doi.org/10.3390/v13091677
APA Style
Appolloni, I., Alessandrini, F., Menotti, L., Avitabile, E., Marubbi, D., Piga, N., Ceresa, D., Piaggio, F., Campadelli-Fiume, G., & Malatesta, P.
(2021). Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma. Viruses, 13(9), 1677.
https://doi.org/10.3390/v13091677